ABCC8 |
Q09428
|
ATP binding cassette subfamily C member 8
|
Transporter
|
8.0E-24 |
0.474 |
0.846 |
AIFM1 |
O95831
|
apoptosis inducing factor mitochondria associated 1
|
Enzyme
|
1.00 |
0.527 |
0.769 |
BACH2 |
Q9BYV9
|
BTB domain and CNC homolog 2
|
|
1.00 |
0.539 |
0.731 |
C1QTNF6 |
Q9BXI9
|
C1q and TNF related 6
|
|
9.0E-06 |
0.682 |
0.577 |
CASP12 |
Q6UXS9
|
caspase 12 (gene/pseudogene)
|
|
1.3E-04 |
0.638 |
0.808 |
CAT |
P04040
|
catalase
|
Enzyme
|
1.6E-10 |
0.359 |
0.962 |
CCL20 |
P78556
|
C-C motif chemokine ligand 20
|
Signaling
|
2.4E-04 |
0.474 |
0.846 |
CD69 |
Q07108
|
CD69 molecule
|
|
3.0E-02 |
0.488 |
0.923 |
CHRM2 |
P08172
|
cholinergic receptor muscarinic 2
|
G-protein coupled receptor
|
0.18 |
0.585 |
0.615 |
CLEC16A |
Q2KHT3
|
C-type lectin domain containing 16A
|
|
0.28 |
0.612 |
0.654 |
CP |
P00450
|
ceruloplasmin
|
Enzyme
|
4.2E-10 |
0.466 |
0.846 |
CRP |
P02741
|
C-reactive protein
|
|
3.7E-03 |
0.299 |
0.962 |
CTSH |
P09668
|
cathepsin H
|
Enzyme
|
1.3E-08 |
0.626 |
0.654 |
DDIT3 |
P35638
|
DNA damage inducible transcript 3
|
|
0.59 |
0.467 |
0.846 |
FGF21 |
Q9NSA1
|
fibroblast growth factor 21
|
Signaling
|
2.9E-02 |
0.485 |
0.769 |
GLIS3 |
Q8NEA6
|
GLIS family zinc finger 3
|
|
5.6E-08 |
0.590 |
0.654 |
HLA-DQA1 |
P01909
|
major histocompatibility complex, class II, DQ alpha 1
|
Immune response
|
2.4E-02 |
0.416 |
0.846 |
HLA-DQB1 |
P01920
|
major histocompatibility complex, class II, DQ beta 1
|
Immune response
|
8.9E-03 |
0.407 |
0.885 |
HLA-DRB1 |
P01911
|
major histocompatibility complex, class II, DR beta 1
|
Immune response
|
1.1E-03 |
0.333 |
0.923 |
HNF1A |
P20823
|
HNF1 homeobox A
|
Nucleic acid binding
|
0.96 |
0.478 |
0.846 |
HP |
P00738
|
haptoglobin
|
Enzyme
|
1.7E-05 |
0.412 |
0.885 |
HSD11B2 |
P80365
|
hydroxysteroid 11-beta dehydrogenase 2
|
Enzyme
|
0.12 |
0.532 |
0.808 |
IFNG |
P01579
|
interferon gamma
|
|
0.47 |
0.288 |
0.962 |
IGF1 |
P05019
|
insulin like growth factor 1
|
|
0.27 |
0.318 |
0.885 |
IL10 |
P22301
|
interleukin 10
|
|
5.9E-03 |
0.281 |
0.923 |